A5062557505- Vaccine Coverage and Hesitancy
- Viral Infections and Vectors
- Global Security and Public Health
- Global Maternal and Child Health
- Mosquito-borne diseases and control
- SARS-CoV-2 and COVID-19 Research
- Viral Infections and Outbreaks Research
- HIV/AIDS Research and Interventions
- HIV, Drug Use, Sexual Risk
- COVID-19 epidemiological studies
- Malaria Research and Control
- Disaster Response and Management
Uganda Virus Research Institute
2023
Centers for Disease Control and Prevention
2020-2022
Centers for Disease Control and Prevention
2022
Historically, malaria has been the predominant cause of acute febrile illness (AFI) in sub-Saharan Africa. However, during last two decades, incidence declined due to concerted public health control efforts, including widespread use rapid diagnostic tests leading increased recognition non-malarial AFI etiologies. Our understanding is limited lack laboratory capacity. We aimed determine etiology three distinct regions Uganda.
On January 28, 2003, the U.S. President's Emergency Plan for AIDS Relief (PEPFAR), largest commitment by any nation to address a single disease in history, was announced.* In April 2004, first person world receive PEPFAR-supported antiretroviral therapy (ART) man aged 34 years Uganda. Effective ART reduces morbidity and mortality among persons with HIV infection (1) prevents both mother-to-child transmission (MTCT) (2) sexual once viral load is suppressed undetectable levels (<200 copies/mL)...
The SARS-CoV-2 Delta variant emerged shortly after COVID-19 vaccines became available in 2021. We describe breakthrough infections a highly vaccinated, well-monitored US Embassy community Kampala, Uganda. Defining infection rates vaccinated populations can help determine public health messaging, guidance, and policy globally.